ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-15399

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an at…

Published Sep 18, 2026 · catalog updated Oct 14, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2025-15399. EPSS is 0.18%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical10.0
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.18%
Remediation
Not established
Affected products
See sources for product scope

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2025-15399

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-15399. EPSS is 0.18%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-352: Cross-Site Request Forgery (CSRF). EPSS 0.18%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Sep 18, 2026 · NIST NVD

    Detected

    IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts.

  2. Oct 14, 2026 · NIST NVD

    Updated

    IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts.

Sources

  • CVE.orgVulnerability recordCVE-2025-15399

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-15399

    30-day exploitation probability 0.2%

    first.org
  • NIST NVDVulnerability recordCVE-2025-15399

    IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 16, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.